Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Geron Corp (NASDAQ:GERN)

2.59
Delayed Data
As of 3:53pm ET
 -0.055 / -2.08%
Today’s Change
2.52
Today|||52-Week Range
5.30
-46.59%
Year-to-Date

Today’s Trading

Previous close2.64
Today’s open2.70
Day’s range2.58 - 2.77
Volume1,797,423
Average volume (3 months)2,879,712
Market cap$417.7M
Dividend yield--
Data as of 3:53pm ET, 02/10/2016

Growth & Valuation

Earnings growth (last year)+23.33%
Earnings growth (this year)+101.74%
Earnings growth (next 5 years)--
Revenue growth (last year)-10.13%
P/E ratioNM
Price/Sales432.79
Price/Book3.18

Competitors

 Today’s
change
Today’s
% change
--Quidel Corp-0.14-0.97%
NTRANatera Inc+0.22+3.30%
QDELQuidel Corp-0.10-0.64%
OXFDOxford Immunotec Glo...+0.13+1.24%
Data as of 3:53pm ET, 02/10/2016

Financials

Next reporting dateMarch 8, 2016
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$1.2M
Annual profit (last year)-$35.7M
Net profit margin-3,093.67%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts

Partner Offers